The new alliance — in which Pfizer Animal Health is the sole biopharmaceutical partner of the AKC Canine Health Foundation (CHF), providing an initial commitment of $ 500,000
over two years — will focus on both
basic and applied
research initiatives, as well as sharing leadership and
scientific expertise.